Nov 14, 2016
Washington Healthcare Update
This Week: Congress returns for a lame-duck session, but it is still unclear what they will do — they must fund the government beyond Dec. 9 when current funding runs
out…Trump arrives and begins transition…EpiPens still make the news.
1. What the Trump Administration Means for Health Care
5. State Activities
6. Regulations Open for Comment
1. What the Trump Administration Means for Health Care
What the Election Means for Health-Related Committees in Congress
Even though Republicans remain in control of the House and Senate there could be some changes in leadership on health-related committees:
Senate Health, Education, Labor and Pensions Committee.
Chairman Lamar Alexander (R-TN) is expected to continue in that position, overseeing FDA user fee reauthorization bills next year that must be passed
before the agreements expire in late 2017.
Sen. Patty Murray (D-WA) is considering a run for the position of Democratic Whip but could also move to be the ranking member of the Senate Appropriations
Committee, or she could remain as the ranking member of the HELP committee. If Murray moves to the Whip position or becomes the top Democrat on
Appropriations, there are rumors that Sen. Bernie Sanders (I-VT) is interested in the top Democratic position on the HELP committee. If Murray becomes the
Democratic Whip and Sanders remains ranking member on the Budget Committee, Sens. Bob Casey (D-PA) and Al Franken (D-MN) are next in seniority for the
Senate Appropriations Committee. Sen. Thad Cochran (R-MS) is expected to stay on as chairman of the Appropriations Committee.
The Democratic leadership of the committee is less clear, because current ranking Democrat Barbara Mikulski (MD) is retiring. A number of senior Democrats
could take the ranking position on the committee, including Sens. Patrick Leahy (VT), Diane Feinstein (CA), Dick Durbin (IL) and Patty Murray (WA).
Sen. Patrick Leahy of Vermont has the seniority. However, it is assumed that he would prefer to retain his position as the top Democrat on the Senate
Senate Finance Committee.
All Finance Committee Republicans who were up for re-election won their races, though committee member Sen. Dan Coats (R-IN) is retiring. Sen. Orrin Hatch
(R-UT) is expected to stay chairman of the committee. Sen. Ron Wyden (D-OR) is expected to remain as the ranking Democrat on the committee.
House Energy & Commerce Committee.
Current Chairman Fred Upton (R-MI) is term limited, opening the position to other members. Two members who have expressed interest in being chairman are
Reps. John Shimkus (R-IL) and Greg Walden (R-OR). Shimkus has seniority and has a long history of voting with GOP leadership. Walden was chair of the
National Republican Congressional Committee.
House Ways & Means Committee.
Chairman Kevin Brady (R-TX) just started his term this year and will stay on. Sander Levin (D-MI) is expected to remain as the ranking Democrat on the
Repealing the Affordable Care Act
President-elect Donald Trump promised to repeal the Affordable Care Act (ACA). His public statements and campaign website left little detail other than
that he would replace the ACA with
- expanding health savings accounts;
- allowing people to deduct the cost of premiums; and
- allowing policies to
be sold across state lines.
His transition website added the following:
To maximize choice and create a dynamic market for health insurance, across state lines. The Administration will work with both Congress and the States to
re-establish high-risk pools – a proven approach to ensuring access to health insurance coverage for individuals who have significant medical expenses and
who have not maintained continuous coverage.
He has not suggested doing away with the more popular parts of the ACA like the protections against being denied coverage because of pre-existing
conditions, or allowing children to stay on the parents’ plan until the children are 26. Nor has Trump discussed dismantling the exchanges, but he has not
proposed a mechanism for individuals to know what plans are available.
The House Republican Plan: “A Better Way”
Because Trump has not provided detail, some have suggested that he might rely on Paul Ryan’s plan, which outlines the same principles but in more detail.
That plan would:
Allow health care to be portable—meaning you could take it from job to job
Expand the use of health savings accounts
Cap open-ended tax break on employer-based premiums—to replace the Cadillac tax
Allow policy sales across state lines
Allow small businesses and individuals to band together to create new pooling mechanisms
Remove the individual and employer mandates
Reform medical liability
In addition, expanding the availability of catastrophic health policies is being considered.
In 2015, a reconciliation bill was passed—but vetoed by Obama—that included language to repeal the individual mandate, ax the ACA’s premium subsidies,
strip the HHS secretary of the authority to run a federal health insurance marketplace starting in 2018, end the three risk mitigation programs, stop
Medicaid expansion and scrap the law’s major taxes. It is highly likely this could serve as the basis of legislation to repeal the ACA.
The question remains of whether the Trump administration would seek to work with any Democrats on this. Democrats have wanted to make changes in the ACA
but have not wanted to provide opportunities for a full repeal. For example, many Democrats want to repeal the Cadillac tax and the device tax repeal
effort also had bipartisan support.
However, the regulatory process could be used to loosen some requirements, for example to exempt more people from the individual mandate.
In addition, Trump has supported block granting Medicaid, a proposal Republicans have supported for years. State budgets could get much tighter if a Trump
administration follows through on converting Medicaid into a block-grant program. Federal Medicaid funds accounted for roughly 15 percent of total state
expenditures in 2014, the National Association of State Budget Officers calculates.
The best way to accomplish repeal would be through the budget reconciliation process because reconciliation needs only a simple majority, not the usual 60
votes in the Senate.
Inspector General Asked to Provide Records, Testify Over EpiPen Misclassification
According to a Nov. 8 letter by Sen.
Chuck Grassley (R-IA) to HHS Inspector General Daniel Levinson, CMS knew in 2009 that Mylan’s EpiPen was misclassified as a generic drug. However, it is
still unclear whether CMS did anything to address the issue before the EpiPen pricing controversy became public this year.
In a July 2009 report, the HHS Inspector General informed CMS that eight drugs were misclassified for the purposes of setting rebates in Medicaid, which
are larger for brand-name drugs. “With respect to those eight, your staff has stated that the EpiPen was one of those drugs and that your office reported
the misclassification to CMS in 2009,” Sen. Grassley wrote in his letter.
Sen. Grassley asked why no one has done anything about the misclassification when CMS knew of the problem for years. In October, Mylan announced a $465
million settlement with the Justice Department to settle claims over the issue, but DOJ has not confirmed the settlement.
The Senate Judiciary Committee will hold a hearing Nov. 30 on the reported settlement. Grassley’s letter directed Inspector General Levinson to provide all
records of OIG’s notifications to CMS about the misclassification of EpiPen.
Bipartisan Letter Asks Mylan to Reimburse DOD for EpiPen Payments
Sens. Chuck Grassley (R-IA), Amy Klobuchar (D-MN) and Richard Blumenthal (D-CT) asked Mylan to explain its plans to reimburse the Defense Department for
EpiPens due to the drug’s misclassification as a generic drug.
“If Mylan’s intention is to ‘move forward and bring resolution to all EpiPen Auto-Injector related matters,’ it is imperative that you quickly resolve this
additional discrepancy and take steps to refund our military for past overpayments,” the lawmakers wrote in a Nov. 7 letter
to the company. They asked for a response by Nov. 18.
Sen. Grassley, the chairman of the Senate Judiciary Committee, and Ranking Member Patrick Leahy (D-VT) also called on the Federal Trade Commission to
review Mylan’s EpiPen contracts with schools for possible antitrust behavior. Mylan reportedly was offering free or low-cost EpiPens to many schools in
return for the schools’ agreement not to purchase competitors’ products.
to see that letter.
CMS Announces $66.1 Million to Support Zika Prevention & Treatment Services
On Nov. 9, CMS announced a funding opportunity providing up to $66.1 million available to support prevention activities and treatment services for health
conditions related to the Zika virus. Congress authorized this funding in the Continuing Appropriations and Military Construction, Veterans Affairs, and
Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act.
In accordance with the Zika Response and Preparedness Act, entities eligible to apply for this funding opportunity include states, territories, tribes or
tribal organizations with active or local transmission of the Zika virus, as confirmed by the Centers for Disease Control and Prevention (CDC). The CDC has
designated American Samoa, Puerto Rico, the U.S. Virgin Islands and Florida as areas with laboratory-confirmed active or local Zika virus transmission. As
such, this emergency funding opportunity is currently available to the territorial and state health departments in these areas.
Through this funding opportunity, up to $66.1 million is available, with $60.6 million directed to Puerto Rico, which has a high incidence of local Zika
cases. Allocations are based on the percentage of active and local Zika cases reported by the CDC and the size of the populations in these areas. Funding
in Puerto Rico will significantly increase the resources and capacity needed to prevent transmission of the virus and provide critical diagnostic,
screening and treatment for pregnant women, newborns and others.
In order to receive funding, applicants must demonstrate their ability to quickly and efficiently expand existing Zika response efforts and further
determine the most effective use and dissemination of funds in their respective jurisdictions. Funds will be available for health care services related to
family planning, diagnostic testing, screening and counseling, medical care, case management and treatment, and improving provider capacity and capability.
CMS Hosting a Quality Payment Program Final Rule Call
CMS is hosting a MLN Connects® Call on Nov. 15 at 1:30 p.m. ET on the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA)
CMS will provide an overview of the Merit-based Incentive Payment System (MIPS) and Advanced Alternative Payment Model (APM) incentive payment provisions
under MACRA, collectively referred to as the Quality Payment Program. Anyone can join the call, and participants may include Medicare Part B
Fee-For-Service clinicians, office managers and administrators, state and national associations that represent health care providers, and other
To register for the call, click here. Registration will close at 12
p.m. ET on the day of the call or when available space has been filled.
Center for Medicaid and CHIP Services Now on Twitter
Follow CMCS at
https://twitter.com/MedicaidGov. CMCS also created a blog.
President Obama Signs Executive Order Advancing the Global Health Security Agenda
On Nov. 4, President Barack Obama signed an
executive order building upon the Global Health Security Agenda (GHSA) that focuses
on combating infectious disease threats like Zika and Ebola.
The president is directing executive departments and agencies to coordinate with other governments, financial institutions and
nongovernmental stakeholders to implement international health regulations and meet the goals of the GHSA, which was launched in 2014.
“Already, we’ve seen historic success: Working with partners in Guinea, Liberia, Sierra Leone, and from around the world, we led the way in ending the
Ebola epidemic in West Africa — and we are leading the way on the Zika response here at home,” National Security Advisor Susan Rice said in a statement.
“The executive order signed today builds on this progress by establishing long-term policy objectives and memorializing a comprehensive framework for the
United States to continue, strengthen, and institutionalize our achievements and use common targets to measure progress.”
The executive order requires the National Security Council to convene an interagency review council to provide guidance to participating agencies,
facilitate and provide a forum to resolve interagency disagreements, and review progress on the work of the GHSA.
Judge Rules House Cannot Participate in Risk-Corridor Lawsuit
On Nov. 7, a federal judge denied the House of Representative’s requests to weigh in on one of the lawsuits over Obamacare’s risk-corridor program. The
House had asked the judge to allow it to argue on behalf of the Obama administration, which is trying to throw out a case brought by Health Republic over
missing risk-corridor payments. The House wanted to tell the court that Congress intentionally limited the payments.
But Judge Margaret M. Sweeney denied the request, saying that the rules of the U.S. Court of Federal Claims do not allow outside parties to weigh in. While
she could have waived the rule, she was swayed by the insurance company’s argument that the court should not allow any new arguments.
Judge Temporarily Halts CMS Rule Banning Mandatory Arbitration
On Nov. 7, a U.S. district court halted implementation of the new policy cracking down on nursing homes’ use of mandatory arbitration agreements. In his
ruling, Judge Michael Mills questioned CMS’s authority to place the sweeping restriction on facilities that receive federal funds, saying it raises
“serious legal questions” about the power that federal agencies hold. He granted a preliminary injunction preventing the arbitration ban from taking effect
until a broader lawsuit against the rule is resolved.
CMS had originally planned to implement the rule on Nov. 28. The American Health Care Association, Community Care of Vicksburg, Great Oaks Rehabilitation,
the Mississippi Health Care Association and Mansfield Long Term Care are suing CMS over the rule. They had requested the injunction, arguing that the
prohibition is unlawful and exceeds the agency’s authority.
The judge did express sympathy for CMS’s intentions, writing that the arbitration ban appears to be good public policy. Yet he remained unconvinced that
CMS had the authority to write the rule in the first place.
SCOTUS Will Not Review Pay-for-delay Case
On Nov. 7, the Supreme Court said it will not review an appeals court
decision that took a broader view of what may qualify as an anti-competitive “pay-for-delay” agreement between brand and generic drug companies.
The court’s refusal to hear the case leaves in place a 3rd Circuit Court of Appeals ruling
from June 2015 finding that drug patent settlements involving a non-cash transfer of value are subject to antitrust scrutiny.
Pay-for-delay agreements typically involve brand drug makers’ paying generic companies to delay introduction of a cheaper generic. However, in this case, SmithKline Beecham Corp. v. King Drug Co. of Florence, the brand drug maker relinquished its right to produce its own “authorized generic” during
the 180-day marketing exclusivity period typically awarded to the first generic company to challenge the brand drug’s patent. In return, the generic
company delayed entry of its product. The lawsuit was brought by drug purchasers who argued they were paying higher prices because of the settlement.
The decision is a win for the FTC, which has been trying to clamp down on non-cash forms of pharma patent settlements it considers anti-competitive. It is
a loss for both brand and generic drug companies, which argue these deals provide leverage to avoid costly and lengthy patent fights.
The appellate court’s decision was based on the Supreme Court’s 2012 decision in FTC v. Actavis. In that landmark case, the Supreme Court ruled that
unexplained large payments from a brand drug maker to a generic company to settle litigation can sometimes violate antitrust laws.
The Solicitor General said the
Supreme Court should let the lower court ruling stand, arguing that the court’s decision in Actavis was not limited to cash payments.
5. State Activities
California: Women Still Struggle to Obtain Birth Control Directly From Pharmacists
In California, women are still struggling to find pharmacists that will dispense birth control without a doctor’s prescription even though legislation was
passed three years ago permitting it. There is no comprehensive list outlining how many of California’s 6,500 pharmacies are participating in the program.
However, some pharmacists say they are reluctant to do so in part because it could take up to an hour to complete the process of filling a prescription for
one patient. This is due to required blood work and having to administer a questionnaire about health issues. California is one of three states where
pharmacists can prescribe birth control.
California: Prescription Drug Pricing Measure Defeated
California’s Proposition 61 was defeated by a 54-46 margin on the November ballot. Proposition 61 sought to lower prescription drug prices by requiring
that state agencies pay no more for medicines than the federal Department of Veterans Affairs. Drug companies led the campaign opposing the proposition,
raising $109 million to defeat the measure.
Opponents of the proposition included drug makers, the California Medical Association and veterans’ groups. They argued the initiative could lead to higher
drug prices for veterans and seniors if the pharmaceutical industry refused to sell the state medicines at lower prices.
Colorado: Measure to Create Universal Health Care System Fails
On Nov. 8, Coloradans voted against creating a universal health care system for the state by a large margin, with about 80 percent voting against the
measure despite support for it from Sen. Bernie Sanders (I-VT) who advocated for a single-payer system during the presidential campaign.
The measure would have covered all residents in Colorado. Those in Medicaid or the Children’s Health Insurance Program would have received benefits
required by federal law as well as ColoradoCare standard benefits. Beneficiaries would not have had any deductibles, and preventive and primary care
services would not have had copayments. The provision would have been funded by a 10 percent payroll tax funded two-thirds by employers and a third by
employees. There would also have been a 10 percent tax of all non-payroll income.
Colorado Democratic Sen. Michael Bennet came out against the proposal, as did Gov. John Hickenlooper (D). Bennet raised concerns with putting an overhaul
of the state’s health care system and a tax increase into the state’s constitution.
ColoradoCare Yes, which had pushed for the bill, spent more than $850,000, but the group was outspent by Coloradans for Coloradans, which spent almost $4
million to defeat the proposition. Anthem spent about a million to defeat the bill, UnitedHealth spent $450,000 and Centura Health spend $250,000.
Connecticut: Hospitals Allege the State Is Illegally Administering Medicaid Program
Connecticut hospitals have filed a petition to
CMS alleging that the state is “illegally administering” its Medicaid program by paying inadequate rates for treatment and imposing a $556 million tax on
providers. “Connecticut’s Medicaid payment system has degraded to a point where provider payments are no longer sufficient to assure efficiency, economy,
quality of care, and adequate access to care for Medicaid beneficiaries,” the petition says. The state’s hospital association and 20 hospitals also
appealed a state court’s ruling on the tax to a state Superior Court. The group’s claim against the tax was denied by two state agencies last month.
Iowa: State Will Pay Medicaid Insurers Additional $33 Million
Several months after a statewide managed care program began, Iowa is increasing the amount of money it pays three private insurers administering Medicaid.
The Iowa Department of Human Services will pay an extra $33.2 million to the health plan, and the federal government will pay an additional $94.5 million
for the increased rates. Gov. Terry Branstad, who has vocally defended the move to statewide managed care as necessary to save taxpayer funds and eliminate
fraud, insists Iowa is still expected to save more than $100 million this year. The savings, he asserts, will result from fewer people enrolled in
higher-cost programs. The state launched the new Medicaid delivery system in April. It pays the insurers per member each month.
Louisiana: Medicaid Expansion Projected to Cost $376 Million More Than Budgeted
In Louisiana, Medicaid expansion is projected to cost $376 million more than expected this year, based on new spending figures from the state’s health
agency. The total estimated cost of expansion is $2.3 billion this fiscal year as a result of the increase in spending. But all of it will be picked up by
the federal government, officials said, because of the ACA’s enhanced match rate for states. There are two main drivers of the higher cost: Louisiana now
projects to enroll 402,000 people in the first year of expansion, up from an earlier estimate of 375,000. And the individuals signing up are older than
expected. As of Oct. 20, 326,000 people had enrolled in expanded coverage that began on July 1.
Massachusetts: CMS Approves State’s 1115 Waiver
On Nov. 4, Massachusetts received CMS approval for a
new, five-year 1115 waiver that will restructure Medicaid payment and delivery systems for nearly 2 million enrollees. The $52.4 billion waiver, which goes
into effect in July 2017, will transition the state’s mostly fee-for-service model to one of provider-led ACOs and managed care. CMS wrote to
Massachusetts that the waiver authorizes $1.8 billion in new Delivery System Reform Incentive payments over five years, as well as $4.8 billion in
supplemental safety net payments to hospitals and other providers. CMS also granted MassHealth approval to launch an ACO pilot program in December.
Vermont: Medicaid Dollars Being Transferred to Primary Care
Vermont has begun reallocating $4 million Medicaid dollars from academic medical centers to primary care doctors under a larger spending bill approved
earlier this year. The state reduced the University of Vermont Medical Center payments by $2.9 million and the Dartmouth-Hitchcock Medical Center by $1
million, as well as $100,000 for out-of-state academic medical centers. With the shift in payments, primary care providers will get $48.9 million—an 8.9
6. Regulations Open for Comment
IRS, Treasury Release Proposed Rule on QHP Benchmarks
The IRS and Treasury Department, in a proposed rule released July 6, proposed to
alter how qualified health plan (QHP) benchmarks are determined so that they
account for the costs of pediatric dental benefits. If finalized, the rule would
go into effect for the 2019 plan year.
Although pediatric dental care is one of the 10 “essential health benefits” that
plans are required to cover under the Affordable Care Act (ACA), several plans
do not include such coverage, and consumers instead buy stand-alone dental
products. Meanwhile, the marketplace determines the amount of tax credits a
family can receive to cover the cost of coverage based on the second-cheapest
However, as the proposed rule said, “because qualified health plans that do not
offer pediatric dental benefits tend to be cheaper than qualified health plans
that cover all ten essential health benefits, the second lowest-cost silver plan
(and therefore the premium tax credit) for taxpayers purchasing coverage through
a Marketplace in which stand-alone dental plans are offered is likely to not
account for the cost of obtaining pediatric dental coverage.”
Treasury and IRS added that the existing rules “frustrate” the goal of making
all essential health benefits affordable to those receiving premium tax credits,
so the administration wants to update its interpretation to ensure all 10
services are addressed.
“Consistent with this interpretation, the proposed regulations provide that for
taxable years beginning after December 31, 2018, if an Exchange offers one or
more silver-level qualified health plans that do not cover pediatric dental
benefits, the applicable benchmark plan is determined by ranking (1) the
premiums for the silver-level qualified health plans that include pediatric
dental benefits offered by the Exchange and (2) the aggregate of the premiums
for the silver-level qualified health plans offered by the Exchange that do not
include pediatric dental benefits plus the portion of the premium allocable to
pediatric dental benefits for stand-alone dental plans offered by the Exchange,”
the proposal said.
The rule aims to create the ranking by adding the premium for the lowest-cost
silver plan that does not include a pediatric dental benefit to the premium for
the cheapest stand-alone dental plan, and the premium for the second-cheapest
silver plan without pediatric dental benefits to that of the second-lowest
stand-alone dental plan. The second-cheapest amount from this combined ranking
would be the taxpayer’s applicable benchmark plan premium, the rule said.
HHS Proposes Updates to Title X Rules
On Sept. 2, HHS
proposed to preclude Title X grant recipients from using criteria in
their selection of family planning providers that are unrelated to the
ability to deliver services effectively.
Since 2011, 13 states have attempted to restrict participation by family
planning providers in Title X based on factors unrelated to their ability to
provide services. The Title X program provides funding for certain family
planning services, including STD screening and treatment, but funding is not
used to pay for abortions. Although Planned Parenthood is not mentioned by
name in the proposed rule, it has often been the subject of defunding
actions by states and Congress.
In the proposed rule, HHS said the effects already felt by the restrictions
in many states justify the department’s rulemaking. HHS said grant
recipients that do not provide services directly would also be required to
follow the updated standards when choosing subrecipients.
HHS also proposed that a tiered structure governing how funds are
distributed would not be allowed unless it can be proven that a
provider in a top tier delivers Title X services more effectively than a
lower-tier provider. According to the Guttmacher Institute, a research
organization that supports reproductive rights, four states have a priority
system for distributing family planning funds, which often disadvantages
family planning centers.
CMS Releases Proposed Rule on Fire Safety Requirements for Dialysis Facilities
On Nov. 3, CMS announced a proposed rule to update Medicare
fire protection guidelines for certain dialysis facilities to ensure that patients are protected from fire while receiving treatment in those facilities.
The new proposed guidelines apply to all dialysis facilities that do not provide one or more exits at grade level from the treatment area level. CMS
previously updated the requirements to include dialysis facilities located adjacent to industrial high-hazard occupancies; however, as dialysis facilities
are not permitted to be located in such areas, the requirement specific to such geographically located facilities will be removed.
The rule adopts, for certain dialysis facilities, updated provisions of the National Fire Protection Association’s (NFPA) 2012 edition of the Life Safety
Code (LSC), as well as provisions of the NFPA’s 2012 edition of the Health Care Facilities Code in order to bring CMS’s requirements more up to date with
current fire safety standards. The LSC is a compilation of fire safety requirements for new and existing buildings, and is updated every three years.
The proposed rule addresses construction, protection and operational features of dialysis facilities to provide safety for Medicare beneficiaries from fire
and smoke. Some of the main requirements laid out in the rule include:
Doors to hazardous areas must be self-closing or must close automatically.
Alcohol-based hand rub dispensers now may be placed in corridors to allow for easier access.
A fire watch or building evacuation is required if the sprinkler system is out of service for more than 10 hours.
Currently, CMS is using the 2000 edition of the LSC to survey dialysis facilities for health and safety compliance. With this proposed rule, CMS is
adopting provisions of the 2012 edition of the LSC and provisions of the 2012 edition of the Health Care Facilities Code, to bring CMS’s requirements more
up to date, and align dialysis facility fire safety requirements with the codes CMS uses to survey other healthcare facilities.
CMS Releases Proposed Notice With Changes to Medicaid National Drug Rebate Agreement
On Nov. 7, CMS issued a proposed notice announcing changes that would be made to the Medicaid National Drug Rebate Agreement (NDRA) for use by the
Secretary of the Department of Health and Human Services and manufacturers under the Medicaid Drug Rebate Program. The NDRA is being updated to incorporate
legislative and regulatory changes that have occurred since the agreement was published in February 1991, as well as to make editorial and structural
revisions, such as references to the updated Office of Management and Budget (OMB)-approved data collection forms and electronic data reporting. There is a
90-day comment period for this proposed notice that will end on Feb. 7, 2017.
For more information, click here.
Comments Due on IMPACT Act Cross-Setting Quality Measure
On Nov. 4, CMS announced that public comments are due Nov. 17 on a cross-setting post-acute care measure under the Improving Medicare Post-Acute Care
Transformation Act of 2014 (IMPACT Act) to further develop and refine
the percentage of residents or patients with pressure ulcers that are new or worsened and language modifications being explored with the term “Pressure
Injury.” CMS seeks feedback on potential updates to measure specifications and items used to calculate the quality measure. Visit the Public Comment webpage
for more information.
New Site Shows Trial Sponsors That Do Not Report Results
Two researchers at the University of Oxford launched a website that shows major drug companies and institutions sponsoring clinical trials—and their
failure rate for reporting results. Sanofi and Novartis top the list followed by the National Cancer Institute.
To see the site, click here.
If you have any questions, contact the following individuals at
Kennan, Senior Vice President
Charlie Iovino, Vice
Caroline Perrin, Research Assistant
Founded in 1998, McGuireWoods Consulting LLC
(MWC) is a full-service public affairs firm offering infrastructure and
economic development, strategic communications & grassroots, and government
relations services. McGuireWoods Consulting is a subsidiary of the
law firm and has been named in The National Law Journal's special annual
report, "The Influence 50," for the past several years. In the most recent
report, McGuireWoods Consulting was ranked 15th of the 1,900 government
relations firms in Washington, D.C.
To sign up for the Weekly Washington Healthcare Update, use our online
McGuireWoods Consulting LLC
2001 K Street
Washington, DC 20006-1040